US SB1847 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 30-1)
Status: Introduced on June 13 2019 - 25% progression, died in committee
Action: 2019-06-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishes several requirements relating to health-insurance coverage of, and access to, over-the-counter contraceptives. Specifically, the bill requires the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury to specify that private health-insurance plans must cover over-the-counter contraceptives that are approved by the Food and Drug Administration (FDA), even without a prescription. Under current law, private health-insurance plans (with some exceptions) must cover FDA-approved prescription contraceptives, without cost-sharing requirements. The bill also prohibits retailers from interfering with an individual's access to oral contraceptives that are meant for routine, daily use and are FDA-approved for use without a prescription.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Affordability is Access Act

Sponsors


History

DateChamberAction
2019-06-13SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB3296 (Related) 2019-06-17 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments

feedback